(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
The Force of Organic product: 10 Assortments That Improve Your Wellbeing - 2Vote in favor of Your #1 4\u00d74 SUVs
- 36 Web-based Staple Help You Can Trust
- 4The most effective method to Stay away from Normal Traps While Recruiting a Material Organization
- 5Newly identified species of Tanzanian tree toad leapfrog the tadpole stage and give birth to toadlets
- Manual for Tracking down Special Store Lodgings
- Vote In favor of Your Favored Sort Of Bevarage
- Immortal Style: Closet Staples for Each Age
- Top Breakfast Food: What's Your Morning Pleasure?
- Man who grabbed Ariana Grande at 'Wicked: For Good' premiere also rushed Katy Perry onstage this year. Who is he and why is he doing this?
- Pope Leo XIV calls for urgent climate action and says God’s creation is 'crying out'
- Best bar-b-que Style: Which One Is Your #1?
- Vote in favor of your Number one natural product
- A definitive Cruiser Standoff: Decision in favor of Your #1 Ride
